Medscape Medical News > FDA Approvals Doug Brunk June 25, 2024 The Food and Drug Administration has approved a topical anticholinergic, sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis in adults and children aged ≥ 9 years. According to a press release from Botanix Pharmaceuticals, which developed the product and will market...
Tag: <span>Axillary Hyperhidrosis</span>
Post
Novel Single-Use Patch Shows Promise for Axillary Hyperhidrosis
Doug Brunk March 19, 2023 NEW ORLEANS — Application of a single-use disposable patch to the axillary area for up to 3 minutes led to statistically significant and clinically meaningful benefit for patients with primary axillary hyperhidrosis, results from a pivotal randomized trial showed. “This is a new kind of device that is going to be a nice tool...